R&D Systems™ Human FGF-23 Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Catalog Number	Mfr. No.	Formulation
2604FG025	R&D Systems™ 2604FG025	Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 EDTA and DTT with BSA as a carrier protein.
2604FG025CF	R&D Systems™ 2604FG025/CF	Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 EDTA and DTT.

Description

The Recombinant Human FGF-23 Protein is derived from NS0. The Recombinant Human FGF-23 Protein has been validated for the following applications: Bioactivity.

Specifications

• Gene ID (Entrez): 8074
• Name: FGF-23
• Source: Mouse myeloma cell line,NS0-derived human FGF-23 protein Tyr25-Ile251 (Arg179Gln),with a C-terminal 6-His tag
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Recombinant: Recombinant

• Molecular Weight (g/mol): 26.1 kDa
• Quantity: 25μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 3 months, 2 to 8° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.